`
Saturday, 23 June 2018

Contract Manufacturing News

  • ADC Bio suggests need of process innovation in early R&D phase

    Contract Manufacturing |  News | 0 Comment | 04 Jun, 2018

    ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and streamline production processes of ADCs will be designed at the clinical development...Read more

  • CMAB Biopharma raises funds worth $34 M

    Contract Manufacturing |  News | 0 Comment | 03 Apr, 2018

    China based CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) providing process development and manufacturing services for biologic produ...Read more

  • The next frontier for CMOs

    Contract Manufacturing |  Opinion | 0 Comment | 18 Oct, 2017

    Long-term success of a pharmaceutical company is very closely linked with its ability to consistently research, patent, develop and market new drugs that can tackle as yet incurable...Read more

  • India and China have potential growth opportunities in CMOs space

    Contract Manufacturing |  Analysis | 0 Comment | 18 Oct, 2017

    According to Research and Markets, the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020. Contract manufacturing has potenti...Read more

  • German firm Evotec to pack up from India

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Singapore: Custom manufacturing German firm, Evotec is closing its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility to answer ...Read more

  • Ajinomoto acquires US firm Althea

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

    Singapore: Japan-headquartered Ajinomoto has entered into a definitive agreement to acquire Althea Technologies, a US-based provider of biopharmaceutical development and manufacturing servi...Read more

  • Pfizer testing unit to move to Singapore

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Pfizer's 20-person surveillance testing group located in Groton will be relocating to Singapore in 2013. The surveillance testing group is a part of the company's Scientific Laboratory Serv...Read more

  • India's Biological E to buy French Valneva's CMO unit

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

    Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-based Biological E. The sale of this unit, which is dedicated to the ...Read more

  • ImaginAb, Singapore Radiopharmaceuticals sign agreement

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: ImaginAb, a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, has signed a master service agreement (MSA) with Singapore Radiopha...Read more

  • WuXi PharmaTech board member steps down

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

    Singapore: Ms Ying Han, member of board of WuXi PharmaTech, has stepped down from the company. WuXi PharmaTech is China based global contract R&D services provider serving the pharmace...Read more

  • WuXi's subsidiary gets manufacturing nod in Japan

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2015

    Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical has received its first approval from the Japan PMDA for the ma...Read more

  • WuXi's API manufacturing passes FDA inspection

    Contract Manufacturing |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2014

    Singapore: China-based WuXiPharmaTech, pharmaceutical, biotechnology and medical device research and development outsourcing company, has succesfully passed the US Food and Drug Administrat...Read more

  • Biovest to spin off CMO business

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2016

    Singapore: Biovest International has decided to spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named Cell Culture Company. Cell Culture ...Read more

  • Marck products get approval in South Africa

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Mumbai: Marck Biosciences, an Indian manufacturer and marketer of sterile dosages and Blow-Fill-Seal (BFS) specialist, was granted approval by the South African Medicines Control Council fo...Read more

  • WuXi Life Science to acquire WuXi PharmaTech for around $3.3 bn

    Contract Manufacturing |  Company results | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2015

    Singapore: WuXi PharmaTech, research and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States,...Read more

  • Astellas sells Kiyosu Plant business to MicroBiopharm Japan

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2015

    Tokyo: Pharma giant Astellas Pharma Inc. has announced that the company and MicroBiopharm Japan Co. Ltd. (MBJ) have concluded an agreement, under which the business of Kiyosu Plant (Kiyosu-...Read more

  • Taiwan, China firms enter contract research alliance

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

    Singapore: Taiwan-based ScinoPharm (Changshu) Pharmaceuticals and Shanghai-based Sundia MediTech entered in a strategic alliance to seek more opportunities for collaboration on contract res...Read more

  • Singapore regulatory grants cGMP certificate to Lonza

    Contract Manufacturing |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Apr, 2014

    Singapore: Biologics manufacturing global firm, Lonza Bioscience, has received cGMP certification from Singapore Health Sciences Authority (HSA). The audit/conformity assessment, performed...Read more

Survey Box

Are complex regulatory frameworks delaying the growth of the molecular diagnostics market in Asia?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls